📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
LTTS ESG Rating Upgraded to 'Leadership' Category; Score Revised to 73 from 69
CRISIL ESG Ratings & Analytics has upgraded L&T Technology Services Limited's (LTTS) overall ESG score from 69 to 73. This revision has resulted in the company's rating category being elevated from 'Strong' to 'Leadership'. The upgrade reflects the company's improved performance across Environmental, Social, and Governance parameters. Such ratings are increasingly critical for attracting institutional capital and ESG-focused investment funds.
Key Highlights
CRISIL ESG Ratings revised the overall ESG score from 'Crisil ESG 69' to 'Crisil ESG 73'.
The company's rating category was upgraded from 'Strong' to the highest 'Leadership' tier.
The rating is an independent assessment of the company's Environmental, Social, and Governance performance.
The disclosure was made in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015.
👀 What to Watch
Investors should recognize this as a positive sign of strengthening corporate governance and sustainability, which may enhance the stock's appeal to institutional investors. No immediate portfolio changes are necessary based on this non-financial metric upgrade.
L&T Finance Allots ₹1,500 Crore NCDs at 8.12% Coupon Rate
L&T Finance Limited has successfully raised ₹1,500 crores through the private placement of 1,50,000 senior, secured, non-convertible debentures (NCDs). The issuance comprised a base size of ₹1,250 crores with a green shoe option of ₹250 crores, which was fully exercised. These NCDs carry a coupon rate of 8.12% per annum and have a tenor of 1,110 days, with maturity scheduled for June 29, 2029. The securities are secured by a first-ranking charge on the company's fixed deposits or standard receivables.
Key Highlights
Allotted 1,50,000 senior, secured, rated, listed, redeemable NCDs with a face value of ₹1,00,000 each.
Total aggregate amount raised is ₹1,500 crores, including the full retention of the ₹250 crore oversubscription option.
The NCDs offer a coupon rate of 8.12% p.a., with the first interest payment due on July 10, 2026.
The instrument has an original tenor of 1,110 days, maturing on June 29, 2029.
Secured by exclusive first ranking charge over identified assets with a minimum cover of 1.0x of the principal and coupon.
👀 What to Watch
This fundraise indicates strong institutional appetite and provides the company with stable long-term capital for its lending business. Investors should monitor how this affects the company's overall cost of funds and Net Interest Margins (NIMs) in future quarters.
Seamec Vessel SEAMEC AGASTYA Off-Hired Due to Technical Reasons
Seamec Limited has announced that its vessel, SEAMEC AGASTYA, was taken off-hire effective June 15, 2026, due to technical reasons. This follows the vessel's previous deployment which was reported on April 21, 2026. The vessel will remain out of service until the technical defects are redressed, at which point the company will provide a further update. This off-hire status implies a temporary cessation of revenue generation from this specific asset.
Key Highlights
Vessel SEAMEC AGASTYA off-hired effective June 15, 2026.
The off-hiring is attributed to technical reasons requiring redressal.
The vessel had been on-hire since approximately April 21, 2026.
Company to provide further intimation once the technical issues are resolved.
👀 What to Watch
Investors should monitor the duration of the off-hire period, as prolonged downtime for a vessel can negatively impact quarterly revenue and operational margins.
RailTel Secures ₹15.78 Crore Order from Munitions India Limited for MPLS Upgradation
RailTel Corporation of India has bagged a domestic work order worth ₹15.78 crore (including taxes) from Munitions India Limited. The project involves upgrading MPLS bandwidth for COMNET 2.0 across 45 units of 7 Defense Public Sector Undertakings (DPSUs) and the Department of Ordnance (DoO) in New Delhi. The contract is scheduled for completion by June 14, 2027. This order reinforces RailTel's strong presence in providing specialized telecom infrastructure to government and defense entities.
Key Highlights
Secured a work order valued at ₹15,77,99,597 (including taxes) from Munitions India Limited.
Scope includes upgradation of MPLS Bandwidth for existing COMNET 2.0 across 45 units.
The project covers 7 DPSUs and the Department of Ordnance (DoO), New Delhi.
Execution timeline is set for completion by June 14, 2027.
The contract is a domestic order with no interest from promoter groups or related party transactions.
👀 What to Watch
Investors should view this as a steady addition to RailTel's order book, confirming its competitive edge in government telecom projects. Maintain a long-term positive outlook as the company continues to secure niche infrastructure mandates.
HCLTech to acquire 10.46% stake in Sarvam AI for INR 1,427.25 crores
HCL Technologies is investing INR 1,427.25 crores to acquire a 10.46% minority stake in Axonwise Private Limited (Sarvam AI). The investment is part of a $300 million Series B round, valuing the Indian sovereign AI startup at a post-money valuation of $1.5 billion. Sarvam AI has shown rapid growth, with its turnover increasing from INR 1.50 crores in FY25 to INR 45.10 crores in FY26. This strategic move is intended to bolster HCLTech's AI capabilities and provide differentiated enterprise AI solutions to its global client base.
Key Highlights
HCLTech is acquiring 41,421 equity shares representing a 10.46% stake for INR 1,427.25 crores.
The investment values Sarvam AI at $1.5 billion, positioning it as a major player in India's sovereign AI space.
Sarvam AI's revenue grew significantly from INR 1.50 crores in FY25 to INR 45.10 crores in FY26.
The transaction is a 100% cash consideration and is expected to be completed within two weeks.
The partnership focuses on developing industry-specific language models for banking, insurance, and government sectors.
👀 What to Watch
Investors should view this as a significant strategic entry into the high-growth AI infrastructure and services market. While the valuation is high relative to current revenue, the partnership strengthens HCLTech's future-readiness in sovereign and enterprise AI.
Promoter Group Aksara Commercial Sells 1.80 Lakh Shares of India Power Corp (DPSCLTD)
India Power Corporation Limited (formerly DPSC Limited), which is currently undergoing Corporate Insolvency Resolution Process (CIRP), has reported a promoter group sell-off. Aksara Commercial Private Limited sold 1,80,190 equity shares on the open market between June 10 and June 11, 2026, for a total consideration of ₹13.55 lakh. This transaction reduced the promoter group entity's stake from 6.23% to 6.21% while the company's Board remains suspended under NCLT orders.
Key Highlights
Aksara Commercial Private Limited (Promoter Group) sold 1,80,190 equity shares via on-market transactions.
The total value of the share disposal was ₹13,54,662, executed on June 10 and 11, 2026.
The promoter group entity's holding decreased from 6,06,54,933 shares (6.23%) to 6,04,74,743 shares (6.21%).
The company is currently under CIRP following an NCLT Hyderabad Bench-I order dated May 15, 2026.
Powers of the Board of Directors remain suspended and are being exercised by the Interim Resolution Professional (IRP).
👀 What to Watch
Investors should remain highly cautious as the company is in insolvency proceedings and a promoter group entity is selling shares. Equity value in CIRP cases is often at significant risk of being wiped out or heavily diluted.
LTM Launches BlueVerse for iRun Targeting 60-70% Automated Resolution
LTM Limited has launched BlueVerse for iRun, an AI-native managed services model designed to automate IT operations using agentic AI. The platform aims to achieve 60-70% automated resolution and 40-60% faster incident closure for enterprise clients. By preventing up to 50% of potential disruptions, the service helps shift IT budgets from maintenance to innovation. This launch strengthens LTM's position in the high-growth AI-driven technology services market.
Key Highlights
Launched BlueVerse for iRun, an AI-native managed services model powered by agentic AI and process-as-code.
Targets 60-70% automated resolution and 40-60% faster incident closure for enterprise IT operations.
Aims to prevent up to 50% of potential disruptions before they occur through pre-emptive, self-learning delivery.
Designed to shift IT spend from maintenance ('run') to innovation ('change'), freeing up capacity for digital transformation.
Integrates application management, cognitive infrastructure, and cybersecurity into a unified intelligence layer.
👀 What to Watch
Investors should monitor the adoption rate of BlueVerse for iRun as it could significantly improve LTM's operating margins through platform-led automation. The success of this AI-native model will be a key indicator of LTM's ability to compete in the evolving 'Agentic AI' era of IT services.
LT Foods to Incorporate Wholly Owned Subsidiary in Australia with AUD 2,100 Initial Capital
LT Foods Limited is incorporating a new wholly owned subsidiary named LT Foods Australia Pty Limited to strengthen its footprint in the Australia and Asia-Pacific regions. The initial capital investment for this 100% owned entity is AUD 2,100, which will be paid in cash. The subsidiary will focus on business development, distribution, and customer engagement within the food industry. This move is a strategic step to establish a direct platform for future growth initiatives in the region.
Key Highlights
Incorporation of LT Foods Australia Pty Limited as a 100% wholly owned subsidiary.
Initial capital investment of AUD 2,100 to be settled via cash consideration.
Strategic objective to enhance distribution and customer engagement in the Asia-Pacific market.
The entity is a fresh incorporation with no prior operating history or turnover.
The transaction is classified as a related party transaction conducted at arm's length.
👀 What to Watch
Investors should view this as a positive long-term strategic move to capture market share in the Asia-Pacific region. While the initial investment is small, the direct presence in Australia could lead to improved margins and better distribution control.
Ravindra Energy Revises Rights Issue Size Upward to ₹2,005.35 Million
Ravindra Energy Limited has issued a corrigendum to its Rights Issue Letter of Offer to adjust for fractional entitlements. The total number of Rights Equity Shares has been increased to 19,854,940 from the previously planned 19,832,834. This adjustment raises the total issue size to ₹2,005.35 million at an issue price of ₹101 per share. The rights ratio remains 1:9 for eligible shareholders as of the June 8, 2026 record date.
Key Highlights
Total Rights Equity Shares increased to 19,854,940 from 19,832,834
Aggregate issue size revised upward to ₹2,005.35 million from ₹2,003.12 million
Issue price maintained at ₹101 per share (including ₹91 premium)
Rights entitlement ratio remains 1 share for every 9 shares held
Estimated net proceeds after ₹16 million in expenses stand at ₹1,989.35 million
👀 What to Watch
Existing shareholders should use the revised figures in the corrigendum when calculating their entitlements and application amounts. The core terms of the issue, including the price and ratio, remain fundamentally unchanged.
Raj Rayon FY26 PAT Jumps 146% to ₹33.99 Cr; Revenue Surges to ₹1,179 Cr
Raj Rayon Industries reported a robust performance for FY26, with annual revenue from operations growing 39% YoY to ₹1,179.72 crore. Net profit for the full year surged 146% to ₹33.99 crore, up from ₹13.81 crore in FY25, reflecting significant operational scaling. While the company faces a modified audit opinion and is seeking a waiver for minimum public shareholding non-compliance, its net worth improved to ₹156.47 crore from ₹122.47 crore.
Key Highlights
Annual Revenue from operations increased by 38.9% YoY to ₹1,179.72 crore in FY26.
Full-year Profit After Tax (PAT) rose significantly to ₹33.99 crore from ₹13.81 crore in the previous year.
Basic Earnings Per Share (EPS) improved to ₹0.61 for FY26 compared to ₹0.25 in FY25.
Company reversed a ₹55 lakh provision related to non-compliance with minimum public shareholding, citing a waiver application.
Management transition: Ms. Ritu Shukla appointed as Company Secretary following the resignation of Mr. Chintan Dharod.
👀 What to Watch
Investors should acknowledge the strong top-line and bottom-line growth but remain cautious regarding the 'modified opinion' in the audit report and the regulatory status of the minimum public shareholding requirement.
India Shelter Finance Fixes June 19 as Record Date for Rs 10 Final Dividend
India Shelter Finance Corporation has announced June 19, 2026, as the record date to determine eligibility for a final dividend of Rs 10 per equity share for FY 2025-26. The dividend is subject to shareholder approval at the upcoming 28th Annual General Meeting scheduled for July 16, 2026. Once approved, the dividend will be paid or dispatched within 30 days from the date of the AGM. This follows the initial recommendation made by the Board of Directors on May 02, 2026.
Key Highlights
Recommended final dividend of Rs 10 per equity share for the financial year 2025-26.
Record date for determining eligible shareholders is fixed as June 19, 2026.
The 28th Annual General Meeting (AGM) is scheduled to take place on July 16, 2026.
Dividend payout will be completed within 30 days of approval at the AGM.
👀 What to Watch
Investors interested in the dividend should ensure they hold the shares before the ex-dividend date to be eligible for the Rs 10 per share payout.
India Shelter Finance Sets June 19 as Record Date for Rs 10 Final Dividend
India Shelter Finance Corporation Limited has fixed June 19, 2026, as the record date to determine shareholder eligibility for a final dividend of Rs 10 per equity share for FY 2025-26. The dividend recommendation was initially made by the Board on May 02, 2026, and is now subject to shareholder approval at the upcoming 28th Annual General Meeting on July 16, 2026. Once approved, the dividend will be paid or dispatched within 30 days of the AGM date.
Key Highlights
Final dividend of Rs 10 per equity share recommended for the financial year 2025-26.
Record date for dividend entitlement is fixed as June 19, 2026.
Shareholder approval will be sought at the 28th Annual General Meeting on July 16, 2026.
Dividend payment will be processed within 30 days from the date of declaration at the AGM.
👀 What to Watch
Investors interested in the Rs 10 per share dividend should ensure they hold the stock before the ex-dividend date, which typically precedes the June 19 record date.
ROHL Launches 56-Key Regenta Devarayah in Tirupati, Expanding Spiritual Tourism Portfolio
Royal Orchid Hotels Limited (ROHL) has announced the opening of Regenta Devarayah in Tirupati, a major pilgrimage destination in Andhra Pradesh. The new 4-star property features 56 rooms, including 2 Presidential Suites, and is strategically located near the Tirumala Venkateswara Temple. A significant operational highlight is its 220 kW vertical solar installation, which provides 80% of the hotel's power consumption. This launch is part of the company's 'Vision 2030' strategy to capitalize on the growing demand for spiritual and leisure tourism.
Key Highlights
Launch of a new 56-key upscale 4-star property in the high-footfall pilgrimage hub of Tirupati.
Strategic location 2 km from Tirupati Railway Station and 15 km from Renigunta International Airport.
First hotel in Andhra Pradesh to use Vertical Solar (220 kW capacity), meeting 80% of its power needs.
Includes banquet facilities for up to 200 people and 3 board rooms to cater to MICE and social events.
The property is part of ROHL's 'Vision 2030' expansion plan to strengthen its presence in key Indian markets.
👀 What to Watch
Investors should view this as a positive step in ROHL's asset-light or subsidiary-led expansion, specifically targeting the resilient spiritual tourism segment. Monitor the company's upcoming quarterly results for improvements in RevPAR and occupancy driven by such new additions.
India Power Corp (DPSCLTD) Concludes 1st Committee of Creditors Meeting Under CIRP
India Power Corporation Limited (IPCL) held its first Committee of Creditors (CoC) meeting on June 12, 2026, following the initiation of the Corporate Insolvency Resolution Process (CIRP) by NCLT Hyderabad on May 15, 2026. The meeting, conducted via video conferencing from 11:30 AM to 1:30 PM, involved deliberations on agenda items under the supervision of the Interim Resolution Professional. This follows the company's admission into insolvency, marking a critical phase in its financial restructuring and debt resolution.
Key Highlights
First CoC meeting held on June 12, 2026, following the NCLT Hyderabad Bench-I order dated May 15, 2026.
The meeting was conducted via Video Conferencing for a duration of 2 hours (11:30 AM to 1:30 PM IST).
Ms. Sreenivasa Mano Ranjani is acting as the Interim Resolution Professional (IRP) for the process.
Agenda items and matters placed before the Committee were deliberated upon by the financial creditors.
👀 What to Watch
Investors should exercise extreme caution as CIRP proceedings often result in significant equity dilution or delisting of the company. Closely monitor future CoC updates regarding the resolution plan and potential recovery for stakeholders.
Alembic Pharma Receives USFDA Final Approval for Tretinoin Cream; Market Size $76 Million
Alembic Pharmaceuticals has received final USFDA approval for Tretinoin Cream USP, 0.05%, used for treating acne vulgaris. The product is a generic equivalent of Retin-A Cream and targets a US market size estimated at $76 million for the twelve months ending March 2026. This approval brings Alembic's cumulative total to 242 ANDA approvals, including 222 final approvals. This development strengthens the company's dermatological portfolio in the US market.
Key Highlights
Received USFDA final approval for Tretinoin Cream USP, 0.05%, indicated for acne vulgaris.
The product addresses an estimated annual market size of US$ 76 million according to IQVIA data.
The approved ANDA is therapeutically equivalent to the reference listed drug Retin-A Cream by Bausch Health.
Alembic now holds a cumulative total of 242 ANDA approvals (222 final and 20 tentative).
👀 What to Watch
Investors should monitor the company's product launch timeline and market share gains in the US generics space. This approval adds a steady revenue stream to the US business, which remains a key growth driver for Alembic.
Emami Increases Stake in IncNut Digital to 60.00% Following Share Acquisition
Emami Limited has acquired an additional 1,064 equity shares in IncNut Digital Private Limited on June 11, 2026. This transaction has increased Emami's total shareholding in the company from 59.69% to 60.00%. The acquisition was completed as per the terms of a previously disclosed Share Subscription and Purchase Agreement. This move further consolidates Emami's controlling interest in the digital-first beauty and wellness platform.
Key Highlights
Acquired 1,064 equity shares of IncNut Digital Private Limited on June 11, 2026.
Total stake in IncNut Digital increased from 59.69% to 60.00%.
The acquisition follows the terms of the Share Subscription and Purchase Agreement dated May 7, 2026.
Consolidates Emami's presence in the digital media and e-commerce beauty segment.
👀 What to Watch
No immediate action is required as this is a marginal 0.31% increase in stake within an existing subsidiary. Investors should monitor how Emami leverages IncNut's digital capabilities to drive growth in its D2C portfolio.
LTM Launches AI 1000 Initiative to Train 1,000+ AI-Certified Forward Deployed Engineers
LTM Limited has launched 'AI 1000', a strategic workforce transformation initiative to develop over 1,000 AI-certified engineers, specifically focusing on the high-demand 'Forward Deployed Engineer' (FDE) role. The program is anchored by a new Center of Excellence (CoE) and utilizes a proprietary AI Readiness Index to identify talent within its 87,000-strong workforce. This initiative builds on LTM's existing foundation of 24,000 AI-trained associates and 15,000 external certifications to drive quantifiable ROI for enterprise clients. The move signals a shift toward high-value, AI-native service delivery models.
Key Highlights
Launched AI 1000 initiative to develop a pool of 1,000+ AI-certified Forward Deployed Engineers (FDEs).
Established a dedicated Center of Excellence (CoE) using a four-stage model: Identify, Enable, Deploy, and Govern.
Leverages a proprietary AI Readiness Index to select high-potential talent from 87,000 total employees.
Builds on a foundation of 6.5 million learning hours and 24,000 already AI-trained associates.
Focuses on bridging the gap between technical LLM/SLM knowledge and business-specific ROI outcomes.
👀 What to Watch
Investors should view this as a positive step toward margin expansion through higher-value AI consulting and engineering services. Monitor future quarterly earnings for improvements in revenue per employee and the scale of AI-led contract wins.
CARE Reaffirms 'CARE A1+' Rating for Alembic Pharma's Rs 1,100 Cr Commercial Paper
CARE Ratings Limited has reaffirmed its 'CARE A1+' credit rating for Alembic Pharmaceuticals Limited's Commercial Paper program. The rating applies to a total facility amount of Rs 1,100.00 Crores as of June 11, 2026. This rating is the highest short-term credit rating possible, indicating a very strong degree of safety regarding timely payment of financial obligations. The reaffirmation suggests that the company maintains a stable financial profile and adequate liquidity to service its short-term debt.
Key Highlights
CARE Ratings Limited reaffirmed the 'CARE A1+' rating for the company's Commercial Paper.
The rating covers a total facility amount of Rs 1,100.00 Crores.
The 'A1+' rating signifies the highest degree of safety for short-term debt instruments.
The rating action was confirmed via a CARE Ratings press release dated June 11, 2026.
👀 What to Watch
Investors can remain confident in the company's short-term creditworthiness and liquidity position. No immediate portfolio changes are necessary as this is a reaffirmation of existing financial strength.
Promoter Khandepar Investments Acquires 3,00,000 Shares of Ravindra Energy via Open Market
Khandepar Investments Private Limited, a promoter entity of Ravindra Energy Limited, has increased its stake by purchasing 3,00,000 equity shares from the open market. The acquisition took place between June 8 and June 10, 2026, for a total consideration of approximately ₹2.16 crores. Such open market purchases by promoters are typically viewed as a sign of confidence in the company's future performance and intrinsic value.
Key Highlights
Promoter group entity Khandepar Investments Private Limited acquired 3,00,000 equity shares.
The shares were purchased through open market transactions between June 8, 2026, and June 10, 2026.
The total value of the acquisition is approximately ₹2,16,00,000 (₹2.16 Crores).
The disclosure was filed under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.
👀 What to Watch
Promoter buying from the open market is a bullish indicator; investors should monitor if this trend of stake consolidation continues as it reflects management's confidence.
Alembic Pharma Receives USFDA Tentative Approval for Larotrectinib; Sole First-to-File Status
Alembic Pharmaceuticals has received tentative USFDA approval for Larotrectinib Capsules (25 mg and 100 mg), used for treating solid tumors. The company is the sole first applicant to file a Paragraph IV certification, which may grant it 180 days of generic marketing exclusivity in the U.S. upon final approval. The market size for this product is estimated at US$ 91 million for the twelve months ending March 2026. This milestone brings Alembic's total USFDA approvals to 241, including 20 tentative approvals.
Key Highlights
Received USFDA tentative approval for Larotrectinib Capsules (25 mg and 100 mg), a generic version of Vitrakvi.
Identified as the sole first applicant with a Paragraph IV certification, potentially securing 180 days of exclusivity.
Target market size for the product is approximately US$ 91 million as of March 2026.
Cumulative USFDA ANDA approvals reached 241, consisting of 221 final and 20 tentative approvals.
👀 What to Watch
Investors should monitor the transition from tentative to final approval, as the sole first-to-file status provides a significant competitive advantage and high-margin potential during the 180-day exclusivity period.
